| Literature DB >> 28029258 |
Jérémy Malinge1,2, Bastien Géraudie3,4, Paul Savel1,2, Valérie Nataf4, Aurélie Prignon3, Claire Provost3, Yongmin Zhang2, Phalla Ou5, Khaldoun Kerrou4, Jean-Noël Talbot3,4, Jean-Michel Siaugue1, Matthieu Sollogoub2, Christine Ménager1.
Abstract
We describe the potentiality of a new liposomal formulation enabling positron emission tomography (PET) and magnetic resonance MR() imaging. The bimodality is achieved by coupling a 68Ga-based radiotracer on the bilayer of magnetic liposomes. In order to enhance the targeting properties obtained under a permanent magnetic field, a sugar moiety was added in the lipid formulation. Two new phospholipids were synthesized, one with a specific chelator of 68Ga (DSPE-PEG-NODAGA) and one with a glucose moiety (DSPE-PEG-glucose). The liposomes were produced according to a fast and safe process, with a high radiolabeling yield. MR and PET imaging were performed on mice bearing human glioblastoma tumors (U87MG) after iv injection. The accumulation of the liposomes in solid tumor is evidenced by MR imaging and the amount is evaluated in vivo and ex vivo according to PET imaging. An efficient magnetic targeting is achieved with these new magnetic liposomes.Entities:
Keywords: MRI; PET; Warburg effect; gallium; liposomes; magnetic nanoparticles; magnetic targeting
Mesh:
Substances:
Year: 2017 PMID: 28029258 DOI: 10.1021/acs.molpharmaceut.6b00794
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939